Thyrocare Technologies informs about outcome of board meeting

31 Oct 2023 Evaluate
Thyrocare Technologies has informed that the Board, at its meeting held today, October 31, 2023, considered and approved the unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2023. Pursuant to Regulation 33(3) of the SEBI Listing Regulations, copies of the standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2023, along with the Limited Review Reports on said financial results issued by the Statutory Auditors of the Company are attached. The said financial results are also being made available on the Company's website at www.thyrocare.com and the extract is being published in one English and one Marathi newspaper.

The above information is a part of company’s filings submitted to BSE.

Thyrocare Tech. Share Price

410.70 -17.40 (-4.06%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7189.25
Max Healthcare Inst 1097.95
Narayana Hrudayalay 1916.45
Aster DM Healthcare 635.10
Global Health 1163.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×